Impella RP with SmartAssist Heart Pump
The only percutaneous pump approved for right heart support with single vascular access, designed for intelligent patient management. Impella RP with SmartAssist is the only right heart pump equipped with dual-sensor technology to assist with pump management. This technology pumps blood from the inferior vena cava to the pulmonary artery. The pump is inserted with venous access and advanced over a wire into the pulmonary artery using standard catheterization techniques. Provides circulatory assistance for up to 14 days in certain patients with a body surface area ≥ 1.5 m2, Delivers flow of greater than 4.0 L/min of blood, Enables biventricular support when the left side is already supported with a left-sided Impella®
Most popular related searches
heart pumping
heart pump
cardiogenic shock
pulmonary arterial
heart support
heart failure
patient management
vascular access
arterial pump
patient support
Right Heart Failure
37% of patients experience right ventricular failure when in cardiogenic shock.1 Impella RP with SmartAssist can support patients and may enable recovery.
The prospective, multi-center FDA PMA post-approval study compared survival in patients who would have met enrollment criteria for the RECOVER RIGHT trial to those who would not have qualified for the trial because they were in cardiogenic shock for more than 48 hours.2 These results, from the Impella RP’s post-approval study, are similar to the survival rate in Impella RP’s pre-approval study, RECOVER RIGHT.3
-
73%
Survival rate for patients treated with Impella RP within 48 hours of cardiogenic shock onset.2